Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction
# Background Deep Learning (DL) has not been well-established as a method to identify high-risk patients among patients with heart failure (HF). # Objectives This study aimed to use DL models to predict hospitalizations, worsening HF events, and 30-day and 90-day readmissions in patients with heart...
| Published in: | Journal of Health Economics and Outcomes Research |
|---|---|
| Main Authors: | Zhibo Wang, Xin Chen, Xi Tan, Lingfeng Yang, Kartik Kannapur, Justin L. Vincent, Garin N. Kessler, Boshu Ru, Mei Yang |
| Format: | Article |
| Language: | English |
| Published: |
Columbia Data Analytics, LLC
2021-07-01
|
| Online Access: | https://doi.org/10.36469/jheor.2021.25753 |
Similar Items
Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction
by: Zhibo Wang, et al.
Published: (2021-07-01)
by: Zhibo Wang, et al.
Published: (2021-07-01)
Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
by: Boshu Ru, et al.
Published: (2023-04-01)
by: Boshu Ru, et al.
Published: (2023-04-01)
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)
by: Robert J.H. Miller, et al.
Published: (2022-06-01)
Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
by: Dan Liu, et al.
Published: (2023-04-01)
by: Dan Liu, et al.
Published: (2023-04-01)
Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fraction
by: Qing Fen Zhou, et al.
Published: (2024-06-01)
by: Qing Fen Zhou, et al.
Published: (2024-06-01)
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
by: Yang Jiang, et al.
Published: (2024-11-01)
by: Yang Jiang, et al.
Published: (2024-11-01)
Plasma metabolomics identifies signatures that distinguish heart failure with reduced and preserved ejection fraction
by: Fawaz Naeem, et al.
Published: (2025-08-01)
by: Fawaz Naeem, et al.
Published: (2025-08-01)
Heart Failure with Reduced Ejection Fraction: The Role of Cardiovascular and Lung Ultrasound beyond Ejection Fraction
by: Syuzanna Shahnazaryan, et al.
Published: (2023-07-01)
by: Syuzanna Shahnazaryan, et al.
Published: (2023-07-01)
Role of interleukins in heart failure with reduced ejection fraction
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)
by: Oliwia Anna Segiet, et al.
Published: (2019-11-01)
Editorial: Edema in heart failure with reduced ejection fraction
by: Inna P. Gladysheva, et al.
Published: (2023-02-01)
by: Inna P. Gladysheva, et al.
Published: (2023-02-01)
Metabolomic fingerprint of heart failure with preserved ejection fraction.
by: Beshay N Zordoky, et al.
Published: (2015-01-01)
by: Beshay N Zordoky, et al.
Published: (2015-01-01)
Intravenous iron for iron deficiency in heart failure with preserved ejection fraction. A multivariate analysis
by: Noverraz Viviane, et al.
Published: (2025-08-01)
by: Noverraz Viviane, et al.
Published: (2025-08-01)
Prognostic Value of Depressive Symptoms for Cardiovascular Events in Female Patients With Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction
by: Hengli Zhao, et al.
Published: (2024-05-01)
by: Hengli Zhao, et al.
Published: (2024-05-01)
Biomarkers in Heart Failure with Preserved Ejection Fraction
by: Antoni Bayes-Genis, et al.
Published: (2022-06-01)
by: Antoni Bayes-Genis, et al.
Published: (2022-06-01)
Heart failure with preserved ejection fraction – onset
by: Branimir Kanazirev
Published: (2021-07-01)
by: Branimir Kanazirev
Published: (2021-07-01)
Heart Failure With Preserved Ejection Fraction and Obesity
by: Arjun Sinha, MD, et al.
Published: (2020-01-01)
by: Arjun Sinha, MD, et al.
Published: (2020-01-01)
Effectiveness and Safety of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction Secondary to Duchenne Muscular Dystrophy-Associated Cardiomyopathy
by: Pankaj Jariwala, et al.
Published: (2023-01-01)
by: Pankaj Jariwala, et al.
Published: (2023-01-01)
Tissue inhibitor of metalloproteinase (TIMP)-1 predicts failure of recovery of ejection fraction in acute heart failure with reduced ejection fraction
by: Chen-Huan Chen, et al.
Published: (2024-09-01)
by: Chen-Huan Chen, et al.
Published: (2024-09-01)
Comparison of mouse models of heart failure with reduced ejection fraction
by: Nabil V. Sayour, et al.
Published: (2025-02-01)
by: Nabil V. Sayour, et al.
Published: (2025-02-01)
Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
by: Pushpraj Patel, et al.
Published: (2024-12-01)
by: Pushpraj Patel, et al.
Published: (2024-12-01)
The Role of Cardiac Imaging in Heart Failure with Reduced Ejection Fraction
by: Rebecca C Gosling, et al.
Published: (2022-06-01)
by: Rebecca C Gosling, et al.
Published: (2022-06-01)
Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly
by: Ivan Milinković, et al.
Published: (2022-05-01)
by: Ivan Milinković, et al.
Published: (2022-05-01)
Vericiguat: The Fifth Harmony of Heart Failure with Reduced Ejection Fraction
by: Luigi Falco, et al.
Published: (2023-09-01)
by: Luigi Falco, et al.
Published: (2023-09-01)
Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction
by: Maria-Angela Moloce, et al.
Published: (2022-07-01)
by: Maria-Angela Moloce, et al.
Published: (2022-07-01)
Role of Vitamin D in heart failure with reduced ejection fraction
by: Dinkar Bhasin
Published: (2016-01-01)
by: Dinkar Bhasin
Published: (2016-01-01)
The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
by: Daniele Masarone, et al.
Published: (2021-08-01)
by: Daniele Masarone, et al.
Published: (2021-08-01)
Obesity Paradox in Heart Failure with Mildly Reduced Ejection Fraction
by: Reinhardt M, et al.
Published: (2024-03-01)
by: Reinhardt M, et al.
Published: (2024-03-01)
New to paradigm for the treatment of heart failure with reduced ejection fraction?
by: Delfín Rodríguez Leyva
Published: (2015-04-01)
by: Delfín Rodríguez Leyva
Published: (2015-04-01)
Role of nutritional supplementation in heart failure with reduced ejection fraction
by: Yash Paul Sharma, et al.
Published: (2021-12-01)
by: Yash Paul Sharma, et al.
Published: (2021-12-01)
Depressive Symptoms, Cardiac Structure and Function, and Risk of Incident Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction in Late Life
by: Katja Vu Bartholdy, et al.
Published: (2021-12-01)
by: Katja Vu Bartholdy, et al.
Published: (2021-12-01)
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
by: Roberta D'Assante, et al.
Published: (2021-04-01)
by: Roberta D'Assante, et al.
Published: (2021-04-01)
Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event
by: Michael M. Givertz, et al.
Published: (2021-06-01)
by: Michael M. Givertz, et al.
Published: (2021-06-01)
Vibrational spectroscopy identifies myocardial chemical modifications in heart failure with preserved ejection fraction
by: Leonardo Pioppi, et al.
Published: (2023-09-01)
by: Leonardo Pioppi, et al.
Published: (2023-09-01)
Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
by: Kenneth D. Varian, et al.
Published: (2020-10-01)
by: Kenneth D. Varian, et al.
Published: (2020-10-01)
Clinical phenotypes of heart failure patients with supranormal ejection fraction
by: Liyan Huang, et al.
Published: (2024-12-01)
by: Liyan Huang, et al.
Published: (2024-12-01)
Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)
Integration of RNA-Seq and Machine Learning Identifies Hub Genes for Empagliflozin Benefitable Heart Failure with Reduced Ejection Fraction
by: Yang Q, et al.
Published: (2023-10-01)
by: Yang Q, et al.
Published: (2023-10-01)
Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
by: Klaus K Witte, et al.
Published: (2021-02-01)
by: Klaus K Witte, et al.
Published: (2021-02-01)
Therapy of heart failure (heart failure with reduced ejection fraction): New sequencing (drug therapy)
by: Avinash Lokre, et al.
Published: (2021-01-01)
by: Avinash Lokre, et al.
Published: (2021-01-01)
Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)
by: Laura Landucci, et al.
Published: (2025-03-01)
Similar Items
-
Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction
by: Zhibo Wang, et al.
Published: (2021-07-01) -
Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study
by: Boshu Ru, et al.
Published: (2023-04-01) -
Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01) -
Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction
by: Dan Liu, et al.
Published: (2023-04-01) -
Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fraction
by: Qing Fen Zhou, et al.
Published: (2024-06-01)
